Assessing factors influencing communities' acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana.
<h4>Background</h4>Guyana is one of four countries in the Latin American Region where lymphatic filariasis (LF) remains endemic. In preparation for the introduction of a new triple drug therapy regimen (ivermectin, diethylcarbamazine, and albendazole (IDA)) in 2019, an acceptability stud...
Guardado en:
Autores principales: | Reza A Niles, Charles R Thickstun, Horace Cox, Daniel Dilliott, Clara R Burgert-Brucker, Emma M Harding-Esch, Nikita Clementson, Annastacia Sampson, Jean Seme Alexandre, Ana C Morice Trejos, Ronaldo G Carvalho Scholte, Alison Krentel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b1b563103284b228fb03e3eaf669527 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
por: Alison Krentel, et al.
Publicado: (2013) -
Global elimination of lymphatic filariasis: a "mass uprising of compassion".
por: David G Addiss
Publicado: (2013) -
Lymphatic filariasis elimination in the Dominican Republic: History, progress, and remaining steps.
por: Manuel Gonzales, et al.
Publicado: (2021) -
The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
por: Doris W Njomo, et al.
Publicado: (2012) -
The emerging story of disability associated with lymphatic filariasis: a critical review.
por: Lynne Michelle Zeldenryk, et al.
Publicado: (2011)